BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18350829)

  • 1. [Protective effect of 3-hydroxypyridine derivatives in extreme conditions].
    Iasnetsov VV
    Aviakosm Ekolog Med; 2007; 41(6):5-12. PubMed ID: 18350829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypoxic effects of various derivatives of 3-hydroxypyridine on isolated rat myocardium].
    Luk'ianova LD; Atabaeva RE; Shepeleva SIu
    Biull Eksp Biol Med; 1993 Apr; 115(4):366-8. PubMed ID: 8049394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
    Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
    Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
    Eksp Klin Farmakol; 2011; 74(12):27-32. PubMed ID: 22379879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
    Volchegorskiĭ IA; Pravdin EV; Uzlova TV
    Eksp Klin Farmakol; 2012; 75(11):22-7. PubMed ID: 23323329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE INFLUENCE OF MEXIDOL AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE ON LIPOFUSCINE CONTENT IN RAT BRAIN UNDER LOCAL PERMANENT ISCHEMIA CONDITIONS].
    Mirzoyan NR; Bagdasaryan NA; Alikhanyan CB; Meliksetyan VS; Bagdasaryan MG; Kukhtarova AM
    Eksp Klin Farmakol; 2015; 78(8):3-6. PubMed ID: 26591573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental substantiation for the use of mexidol and 3-hydroxypyridine fumarate in chronic myocardial injury.
    Zamotaeva MN; Chairkin IN; Inchina VI; Drozdov IA
    Bull Exp Biol Med; 2013 Jun; 155(2):212-3. PubMed ID: 24130992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of mexidol on the rat periodontium during hypokinesia].
    Kovalenko EG
    Fiziol Zh (1994); 1994; 40(3-4):87-93. PubMed ID: 7621961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydroxypyridine derivatives mexidol and emoxypin on the reparative processes in rabbit eye on the models of corneal epithelial defect and conjunctival ischemia.
    Chesnokova NB; Beznos OV; Pavlenko TA; Zabozlaev AA; Pavlova MV
    Bull Exp Biol Med; 2015 Jan; 158(3):346-8. PubMed ID: 25573366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute radiation sickness in experiment. Efficacy of mexidol].
    Deshevoĭ IuB; Moroz BB; Cukoian GV; Voronina TA; Lebedev VG; Lyrshchikova AV
    Patol Fiziol Eksp Ter; 2007; (3):22-4. PubMed ID: 17933047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energotropic effect of succinate-containing derivatives of 3-hydroxypyridine.
    Lukyanova LD; Germanova EL; Tsybina TA; Chernobaeva GN
    Bull Exp Biol Med; 2009 Oct; 148(4):587-91. PubMed ID: 20396747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of actoprotective action of succinic acid's derivatives].
    Iakovlieva IIu
    Lik Sprava; 2013; (3):78-85. PubMed ID: 25016753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of mexidol in pain syndromes].
    Danilova ED; Grafova VN; Voronina TA; Reshetniak VK
    Eksp Klin Farmakol; 1995; 58(3):17-20. PubMed ID: 7663286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
    Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Malkin MP; Pryakhina KE; Kalugina AV
    Bull Exp Biol Med; 2015 Apr; 158(6):756-61. PubMed ID: 25894772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Possibility of Correction of Doxorubicin-Induced Chronic Heart Failure in the Experiment with 3-Hydroxypyridine Acetylcysteinate and 3-Hydroxypyridine Succinate.
    Zamotaeva MN; Inchina VI; Konorev VV; Kuznetsov YV; Kuz'michev ND
    Bull Exp Biol Med; 2018 Jul; 165(3):344-346. PubMed ID: 30006879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 3-hydroxypyridine derivatives on the central nervous system].
    Val'dman AV; Voronina TA; Smirnov LD; Tilekeeva UM; Diumaev KM
    Biull Eksp Biol Med; 1985 Jan; 99(1):60-2. PubMed ID: 4038464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental evaluation of actoprotective activity of nitrogen-containing heterocyclic compounds derivatives in extreme conditions].
    Tsublova EG; Ivanova TG; Ivanova TN; Iasnetsov VV
    Voen Med Zh; 2013 Jul; 334(7):17-20. PubMed ID: 24341005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the antihypoxic properties of 3-hydroxypyridine-class antioxidants].
    Tilekeeva UM; Voronina TA; Kuz'min VI; Sopyev DA; Aliev AN
    Farmakol Toksikol; 1987; 50(1):74-7. PubMed ID: 3556556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of anti-hypoxic action of 3-hydroxypyridine derivatives in animals with some types of experimental pathology].
    Iasnetsov VV; Ivanov IuV; Karsanova SK; Chel'naia NA; Skachilova SIa; Savina NV; Solov'ev NA; Filipenko TV; Luk'ianov VN
    Aviakosm Ekolog Med; 2010; 44(3):57-60. PubMed ID: 21033401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.